| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,288,000 | 2,138,000 | 2,123,000 | 2,403,000 | | Cost of Revenue | 1,277,000 | 1,190,000 | 1,195,000 | 1,418,000 | | | Gross Profit | 1,011,000 | 948,000 | 928,000 | 985,000 | | | Operating Expenses | | Research Development | 20,000 | 36,000 |
-
| 25,000 | | Selling General and Administrative | 575,000 | 276,000 | 269,000 | 281,000 | | Non Recurring |
-
| (18,000) | 18,000 | 159,000 | | Others | 217,000 | 207,000 | 199,000 | 206,000 | | | | Total Operating Expenses |
-
| 501,000 |
-
| 671,000 | | | | Operating Income or Loss | 199,000 | 447,000 | 442,000 | 314,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (25,000) |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 174,000 | 447,000 | 442,000 | 314,000 | | Interest Expense | 32,000 | 33,000 | 35,000 | 49,000 | | Income Before Tax | 142,000 | 414,000 | 407,000 | 265,000 | | Income Tax Expense | (187,000) | 109,000 | 114,000 | 67,000 | | Minority Interest |
-
| 8,000 | (8,000) | (6,000) | | | | Net Income From Continuing Ops | 336,000 | 319,000 | 290,000 | 200,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 336,000 | 319,000 | 290,000 | 200,000 | | Preferred Stock And Other Adjustments | (11,000) | (20,000) |
-
|
-
| | | Net Income Applicable To Common Shares | $325,000 | $299,000 | $290,000 | $200,000 |
|
0.20% Nasdaq 
0.14%
Income Statement
